 - Participant has a history of hepatitis A antibody immunoglobulin M IgM, hepatitis B virus surface antigen HBsAg, or hepatitis C virus antibody anti-HCV positive, or other clinically active liver disease, or tests positive for hepatitis A antibody IgM, HBsAg or anti HCV at screening 